tert-Butyl [[4-(2-pyridinyl)phenyl]methylene]hydrazinecarboxylate

We are tert-Butyl [[4-(2-pyridinyl)phenyl]methylene]hydrazinecarboxylate CAS:198904-84-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: tert-Butyl [[4-(2-pyridinyl)phenyl]methylene]hydrazinecarboxylate
CAS.NO:198904-84-6
Synonyms:
pyridinyl)phenyl]methylene]-,1,1-dimethylethyl ester

Molecular Formula:C17H19N3O2
Molecular Weight:297.35200

Physical and Chemical Properties:
Density: 1.102g/cm3
Boiling point: /
Melting point: /
Flash point: /
Refractive index: 1.559

Specification:
Appearance:white crystalline powder
Purity:≥98%
Moisture Content: ≤0.5%
Impurity: ≤0.1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Atazanavir sulfate CAS:229975-97-7
Intermediates of Atazanavir CAS:198904-31-3

Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.2-chloro-4,6-di(naphthalen-1-yl)-1,3,5-triazine Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.2,4-Dichloropyrimidine Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.trans-2-Pentenal CAS:1576-87-0 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.